关于将疫苗纳入中国国家免疫计划的公众偏好和优先事项:离散选择实验

Lingli Zhang1, Xin Li2,3,4,5, Jiali Chen3

  • 1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

PubMed
概括

在中国,公众偏好将疫苗纳入疫苗.